Markers of cell cycle-mediated drug resistance and prognosis of patients receiving preoperative combined modality therapy for rectal cancer.

Authors

Publication/Presentation Date

11-1-2004

Volume

11

Issue

11

First Page

949

Last Page

950

ISSN

1068-9265

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

15525820

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS